Skip to main content
Tech.euFundingExplorerBeta

Vantis

Vantis GmbH is a Digital solution for Chronic cardiovascular diseases that requires personalized ongoing treatment for decades.

Total raised
€14M
€13,800,000
Funding rounds
2
Investors
8
distinct backers
Active since
2021-05
latest 2025-03

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood55
base rate 44% for Series A
  • In typical raise window
  • Up-round momentum
  • Low backer re-investment
Exit likelihood12
base rate 12% (2+ rounds)

    Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

    Similar companies

    same sector or country